top of page
Profile
Join date: Mar 23, 2023
Posts (33)
Jan 15, 2025 ∙ 3 min
Laxxon Medical Announces Positive Pilot PK Study Results (in Pigs) for Groundbreaking Oral GLP-1 Dosage Form
[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug...
36
0
Jan 7, 2025 ∙ 1 min
Laxxon Medical to Participate in 27th Annual Needham Growth Conference
NEW YORK, NY / ACCESSWIRE / January 7, 2024 / Laxxon Medical, a leading pharma-technology company pioneering a new generation of...
18
0
Oct 14, 2024 ∙ 3 min
Laxxon Medical to Present Innovative Oral GLP-1 Agonist including Multi-Compartment Micro-Tablet Form at 2024 BIO-Europe Convention, Aiming to Enhance Compliance for Special Patient Groups
Laxxon is seeking out-licensing opportunities for lead asset LXM.2, or co-developments projects with 3DSP platform technology SPID® at...
128
0
Laxxon Medical
Writer
More actions
bottom of page